The Bayer AG annual shareholders’ meeting got underway Tuesday in Germany, drawing the attention of not only investors and analysts but also activists, lawyers and cancer patients who want to see Bayer make amends for alleged misdeeds by Monsanto, which Bayer bought two years ago.
The meeting was to be an in-person event in Bonn, Germany but due to fears about large gatherings that could spread the Covid-19 virus, Bayer instead is hosting a video webcast of the meeting.
On Monday the company announced a “good start to 2020,” reporting higher sales and profits through all divisions driven in part by strong demand within its Consumer Health division related to the Covid-19 pandemic.
The shareholders’ meeting comes as Bayer is facing legal claims in the United States brought by roughly 52,500 plaintiffs alleging that exposure to Monsanto’s glyphosate-based herbicides such as Roundup caused them or their loved ones to develop non-Hodgkin lymphoma (NHL).